Anika Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | 4.5% | 4.5% | — |
| FY2010 | 5.1% | 4.5% | 3.3% |
| FY2011 | 8.9% | 8.1% | 6.4% |
| FY2012 | 10.8% | 10.1% | 8.3% |
| FY2013 | 15.2% | 15.2% | 13.2% |
| FY2014 | 21.5% | 21.5% | 19.9% |
| FY2015 | 14.6% | 14.6% | 13.0% |
| FY2016 | 14.6% | 14.6% | 13.5% |
| FY2017 | 12.1% | 12.1% | 11.3% |
| FY2018 | 7.1% | 7.1% | 6.7% |
| FY2019 | 9.4% | 9.4% | 8.2% |
| FY2020 | -8.8% | -8.8% | -6.6% |
| FY2021 | 1.4% | 1.4% | 1.2% |
| FY2022 | -5.2% | -5.2% | -4.3% |
| FY2023 | -38.9% | -38.9% | -30.5% |
| FY2024 | -36.6% | -36.6% | -27.8% |
| FY2025 | -7.6% | -7.6% | -5.7% |